NDC 17312-170 – Chronic Fatigue Therapy
Scutellaria Lateriflora 6 [hp_X]/1; Thuja Occidentalis Leafy Twig 6 [hp_X]/1; Ginkgo 3 [hp_X]/1; Chelidonium Majus 6 [hp_X]/1; Epinephrine 7 [hp_X]/1;… · Tablet, Orally Disintegrating · Oral
Product NDC17312-170
Product details
- Brand name
- Chronic Fatigue Therapy
- Generic name
- Epinephrine, Gold, Chelidonium Majus, Echinacea, Ginkgo, Helleborus Niger, Phosphoric Acid, Scutellaria Lateriflora, Thuja Occidentalis
- Labeler
- TRP Company
- Dosage form
- Tablet, Orally Disintegrating
- Route
- Oral
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketed since
- August 20, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Catecholamine; Standardized Chemical Allergen; alpha-Adrenergic Agonist; beta-Adrenergic Agonist
Active ingredients
- Scutellaria Lateriflora 6 [hp_X]/1
- Thuja Occidentalis Leafy Twig 6 [hp_X]/1
- Ginkgo 3 [hp_X]/1
- Chelidonium Majus 6 [hp_X]/1
- Epinephrine 7 [hp_X]/1
- Phosphoric Acid 6 [hp_X]/1
- Echinacea, Unspecified 3 [hp_X]/1
- Gold 8 [hp_X]/1
- Helleborus Niger Root 6 [hp_X]/1
Uses, dosage, side effects and warnings for Chronic Fatigue Therapy →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 17312-170-14 | 1 BOTTLE in 1 PACKAGE (17312-170-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE | Aug 20, 2018 |